Mp84-20 Bioinformatic Analysis Utilizing the Androgenic Suppressive Effect Identified Promising Candidate Drugs for Reprogramming Docetaxel-Resistant Castration-Resistant Prostate Cancer
Journal of Urology- Netherlands
doi 10.1016/j.juro.2016.02.2244
Full Text
Abstract
Available in
Categories
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)